Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Antifibroproliferative agents emerge from FibroGen/Zeneca collaboration

June 8, 1999

Small-molecule inhibitors of proinflammatory cytokines developed at Boehringer Ingelheim

June 8, 1999

D2E7 plus methotrexate: a safe and effective treatment for rheumatoid arthritis

June 8, 1999

Merck Frosst investigates alternatives to conventional NSAIDs

June 8, 1999

EULAR meeting highlights: overview of clinical experience with Reumacon

June 8, 1999

In vitro studies shed light on the mechanism of action of triptolide

June 7, 1999

Lornoxicam available in Germany for arthritic conditions

June 7, 1999

Idec presents interim phase I/II results with clenoliximab at EULAR congress

June 7, 1999

Antiinflammatory thiadiazole amides act by inhibiting beta2 integrins

June 4, 1999

Merck presents integrin antagonists with cell adhesion-inhibitory activity

June 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Researchers hit back after colleagues removed from ADA meeting
BioWorld
Former principal officers of the American Diabetes Association (ADA) have hit back at the association’s board and CEO after it prohibited the distribution of an...